» Authors » P-L Kellokumpu-Lehtinen

P-L Kellokumpu-Lehtinen

Explore the profile of P-L Kellokumpu-Lehtinen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 10
Citations 726
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Wu X, Reinikainen P, Kapanen M, Vierikko T, Ryymin P, Kellokumpu-Lehtinen P
Diagn Interv Imaging . 2019 Jul; 100(11):699-708. PMID: 31257114
Purpose: To evaluate the utility of multi-parametric magnetic resonance imaging (MP-MRI), including dynamic contrast-enhanced MRI and diffusion-weighted MRI, for monitoring tumor tissue changes after volumetric-modulated arc radiotherapy in localized prostate...
2.
Mannisto S, Vahamurto P, Pollari M, Clausen M, Jyrkkio S, Kellokumpu-Lehtinen P, et al.
Eur J Cancer . 2019 May; 115:27-36. PMID: 31082690
Background: Testicular lymphoma is a rare malignancy affecting mainly elderly men, the majority representing diffuse large B-cell lymphoma (DLBCL). Its relapse rate is higher than that of nodal DLBCL, often...
3.
Wu X, Reinikainen P, Vanhanen A, Kapanen M, Vierikko T, Ryymin P, et al.
Diagn Interv Imaging . 2016 Oct; 98(1):63-71. PMID: 27687831
Objectives: To investigate whether diffusion-weighted imaging (DWI) apparent diffusion coefficient (ADC) correlates with prostate cancer aggressiveness and further to compare the diagnostic performance of ADC and normalized ADC (nADC: normalized...
4.
Loi S, Michiels S, Salgado R, Sirtaine N, Jose V, Fumagalli D, et al.
Ann Oncol . 2014 Mar; 25(8):1544-50. PMID: 24608200
Background: We have previously shown the prognostic importance of tumor-infiltrating lymphocytes (TILs) in newly diagnosed triple-negative breast cancer (TNBC) using tumor samples from a large clinical trial cohort. In this...
5.
Salonen P, Rantanen A, Kellokumpu-Lehtinen P, Huhtala H, Kaunonen M
Eur J Cancer Care (Engl) . 2013 Nov; 23(2):274-83. PMID: 24237363
The purpose of this study was to evaluate prospectively the quality of life (QOL) and received social support from the network and nurses in significant others of breast cancer patients...
6.
Nikander R, Sievanen H, Ojala K, Kellokumpu-Lehtinen P, Palva T, Blomqvist C, et al.
J Musculoskelet Neuronal Interact . 2012 Sep; 12(3):127-35. PMID: 22947544
In this 12-month RCT, we examined whether aerobic impact exercise training (3x/week) could facilitate breast cancer survivors' recovery by enhancing their bone structural strength, physical performance and body composition. After...
7.
Kellokumpu-Lehtinen P, Hjalm-Eriksson M, Thellenberg-Karlsson C, Astrom L, Franzen L, Marttila T, et al.
Prostate Cancer Prostatic Dis . 2012 May; 15(3):303-7. PMID: 22546837
Background: Radical radiotherapy (RT) combined with androgen deprivation therapy is currently the standard treatment for elderly patients with localized intermediate- or high-risk prostate cancer (PC). To increase the recurrence-free and...
8.
Joensuu H, Sperinde J, Leinonen M, Huang W, Weidler J, Bono P, et al.
Ann Oncol . 2011 Feb; 22(9):2007-2013. PMID: 21285132
Background: It is unknown how a very high tumor total HER2 (human epidermal growth factor receptor-2) content (H2T) influences outcome in early breast cancer treated with adjuvant trastuzumab plus chemotherapy....
9.
Bono P, Kellokumpu-Lehtinen P, Alanko T, Kokko R, Asola R, Turpeenniemi-Hujanen T, et al.
Ann Oncol . 2009 Jan; 20(3):595-6. PMID: 19153112
No abstract available.
10.
Harrison L, Dastidar P, Eskola H, Jarvenpaa R, Pertovaara H, Luukkaala T, et al.
Comput Biol Med . 2008 Mar; 38(4):519-24. PMID: 18342845
The aim here is to show that texture parameters of magnetic resonance imaging (MRI) data changes in lymphoma tissue during chemotherapy. Ten patients having non-Hodgkin lymphoma masses in the abdomen...